TrialCancer immunology, immunotherapy : CII2025

Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM.

Henry G Withers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.